Report cover image

Thoracic Catheters Market Size, Share & Trends Analysis Report By Material (PVC, Silicone), By Product (Thoracostomy Tubes, Pleural Drainage Catheters), By End-use (Hospitals, Specialty Clinics), By Application, By Region, And Segment Forecasts, 2026 - 20

Published Dec 29, 2025
Length 120 Pages
SKU # GV20723951

Description

Thoracic Catheters Market Summary

The global thoracic catheters market size was estimated at USD 484.43 million in 2025 and is projected to reach USD 748.91 million by 2033, growing at a CAGR of 5.69% from 2026 to 2033. The rising demand for minimally invasive aesthetic procedures, the growing trend of ageless beauty, and increasing awareness among the young population about physical appearance are some of the major factors driving the growth of the market.

The increasing number of thoracic and pulmonary surgeries, including minimally invasive and robotic-assisted procedures, has driven up the demand for advanced catheter systems to ensure efficient fluid evacuation and promote patient recovery. According to data published by the UK Health Security Agency and the Centre for Climate and Health Security in August 2025, asthma is prevalent in the UK, with 7.2 million people suffering from the condition.

The increasing prevalence of respiratory and thoracic conditions such as pleural effusion, pneumothorax, lung cancer, chronic obstructive pulmonary disease, and post-surgical complications is a primary factor driving the thoracic catheter industry. These conditions often lead to the accumulation of air or fluid in the pleural cavity, necessitating the use of thoracic catheters for drainage and respiratory support. The global rise in smoking rates, air pollution, and lifestyle-related lung disorders has further contributed to the growing number of thoracic interventions. As more patients require effective and minimally invasive solutions for pleural management, the demand for advanced catheters with improved safety, comfort, and infection control continues to increase. This trend is expected to sustain strong market growth, particularly in hospitals and critical care units that frequently manage complex thoracic and pulmonary cases.

Global Thoracic Catheters Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global thoracic catheters market report based on the material, product, application, end use, and region:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Thoracostomy Tubes
  • Pleural Drainage Catheters
  • Others
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Silicone
  • Polyurethane
  • PVC
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Pneumothorax
  • Pleural Effusion
  • Hemothorax
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Material
1.1.2. Product
1.1.3. Application
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity price analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Material outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Thoracic Catheters Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of respiratory and thoracic conditions
3.2.1.2. Increasing number of thoracic surgeries and minimally invasive procedures
3.2.1.3. Technological innovation
3.2.2. Market Restraint Analysis
3.2.2.1. Risk of complications and infections
3.2.2.2. High cost of advanced devices
3.2.3. Market Challenge Analysis
3.2.3.1. Availability of alternative treatments
3.2.3.2. Regulatory and compliance barriers
3.2.4. Market Opportunity Analysis
3.2.4.1. Rising demand for minimally invasive procedures
3.2.4.2. Expanding healthcare infrastructure in emerging markets
3.3. Thoracic Catheters Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Thoracic Catheters Market: Material Estimates & Trend Analysis
4.1. Thoracic Catheters Market: Material Dashboard
4.2. Thoracic Catheters Market: Material Movement Analysis
4.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by Material, 2021 to 2033 (USD Million)
4.3.1. PVC
4.3.1.1. PVC market estimates and forecast 2021 to 2033, (USD Million)
4.3.2. Silicone
4.3.2.1. Silicone market estimates and forecast 2021 to 2033s, (USD Million)
4.3.3. Polyurethane
4.3.3.1. Polyurethane market estimates and forecast 2021 to 2033s, (USD Million)
4.3.4. Others
4.3.4.1. Others market estimates and forecast 2021 to 2033s, (USD Million)
Chapter 5. Thoracic Catheters Market: Product Estimates & Trend Analysis
5.1. Thoracic Catheters Market: Product Dashboard
5.2. Thoracic Catheters Market: Product Movement Analysis
5.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.3.1. Thoracostomy Tubes
5.3.1.1. Thoracostomy tubes market estimates and forecast 2021 to 2033, (USD Million)
5.3.2. Pleural Drainage Catheters
5.3.2.1. Pleural drainage catheters market estimates and forecast 2021 to 2033, (USD Million)
5.3.3. Others
5.3.3.1. Others market estimates and forecast 2021 to 2033, (USD Million)
Chapter 6. Thoracic Catheters Market: Application Estimates & Trend Analysis
6.1. Thoracic Catheters Market: Application Dashboard
6.2. Thoracic Catheters Market: Application Movement Analysis
6.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.3.1. Pneumothorax
6.3.1.1. Pneumothorax market estimates and forecast 2021 to 2033, (USD Million)
6.3.2. Pleural Effusion
6.3.2.1. Pleural effusion market estimates and forecast 2021 to 2033, (USD Million)
6.3.3. Hemothorax
6.3.3.1. Hemothorax market estimates and forecast 2021 to 2033, (USD Million)
6.3.4. Others
6.3.4.1. Others market estimates and forecast 2021 to 2033, (USD Million)
Chapter 7. Thoracic Catheters Market: End Use Estimates & Trend Analysis
7.1. Thoracic Catheters Market: End Use Dashboard
7.2. Thoracic Catheters Market: End Use Movement Analysis
7.3. Thoracic Catheters Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.3.1. Hospitals
7.3.1.1. Hospitals market estimates and forecast 2021 to 2033, (USD Million)
7.3.2. Specialty Clinics
7.3.2.1. Specialty clinics market estimates and forecast 2021 to 2033, (USD Million)
7.3.3. Ambulatory Surgical Centers (ASCs)
7.3.3.1. Ambulatory Surgical Centers (ASCs) market estimates and forecast 2021 to 2033, (USD Million)
7.3.4. Others
7.3.4.1. Others market estimates and forecast 2021 to 2033, (USD Million)
Chapter 8. Thoracic Catheters Market: Regional Estimates & Trend Analysis by Material, Product, Application, End Use, and Region
8.1. Global Thoracic Catheters Market: Regional Dashboard
8.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
8.3. North America
8.3.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
8.3.2. U.S.
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement scenario
8.3.2.3. Competitive scenario
8.3.2.4. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
8.3.3. Canada
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement scenario
8.3.3.3. Competitive scenario
8.3.3.4. Canada market estimates and forecast, 2021 - 2033 (USD Million)
8.3.4. Mexico
8.3.4.1. Key country dynamics
8.3.4.2. Regulatory framework/ reimbursement scenario
8.3.4.3. Competitive scenario
8.3.4.4. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
8.4. Europe
8.4.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
8.4.2. UK
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement scenario
8.4.2.3. Competitive scenario
8.4.2.4. UK market estimates and forecast, 2021 - 2033 (USD Million)
8.4.3. Germany
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement scenario
8.4.3.3. Competitive scenario
8.4.3.4. Germany market estimates and forecast, 2021 - 2033 (USD Million)
8.4.4. France
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement scenario
8.4.4.3. Competitive scenario
8.4.4.4. France market estimates and forecast, 2021 - 2033 (USD Million)
8.4.5. Italy
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement scenario
8.4.5.3. Competitive scenario
8.4.5.4. Italy market estimates and forecast, 2021 - 2033 (USD Million)
8.4.6. Spain
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement scenario
8.4.6.3. Competitive scenario
8.4.6.4. Spain market estimates and forecast, 2021 - 2033 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement scenario
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
8.4.8. Norway
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement scenario
8.4.8.3. Competitive scenario
8.4.8.4. Norway market estimates and forecast, 2021 - 2033 (USD Million)
8.4.9. Denmark
8.4.9.1. Key country dynamics
8.4.9.2. Regulatory framework/ reimbursement scenario
8.4.9.3. Competitive scenario
8.4.9.4. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
8.5. Asia Pacific
8.5.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement scenario
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecast, 2021 - 2033 (USD Million)
8.5.3. Japan
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement scenario
8.5.3.3. Competitive scenario
8.5.3.4. Japan market estimates and forecast, 2021 - 2033 (USD Million)
8.5.4. India
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement scenario
8.5.4.3. Competitive scenario
8.5.4.4. India market estimates and forecast, 2021 - 2033 (USD Million)
8.5.5. Australia
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement scenario
8.5.5.3. Competitive scenario
8.5.5.4. Australia market estimates and forecast, 2021 - 2033 (USD Million)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement scenario
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
8.5.7. South Korea
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework/ reimbursement scenario
8.5.7.3. Competitive scenario
8.5.7.4. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
8.6. Latin America
8.6.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
8.6.2. Brazil
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement scenario
8.6.2.3. Competitive scenario
8.6.2.4. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement scenario
8.6.3.3. Competitive scenario
8.6.3.4. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
8.7. MEA
8.7.1. Market Estimates and Forecasts 2021 to 2033, (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement scenario
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
8.7.3. South Africa
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement scenario
8.7.3.3. Competitive scenario
8.7.3.4. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
8.7.4. UAE
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement scenario
8.7.4.3. Competitive scenario
8.7.4.4. UAE market estimates and forecast, 2021 - 2033 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/ reimbursement scenario
8.7.5.3. Competitive scenario
8.7.5.4. Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key company market share analysis, 2025
9.3.3. Teleflex Incorporated
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Product benchmarking
9.3.3.4. Strategic initiatives
9.3.4. Smiths Medical (ICU Medical, Inc.)
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. B. Braun Melsungen AG
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Vygon SA
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Cook Medical
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Terumo Corporation
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Nipro Corporation
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Asahi Kasei Corporation
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Becton, Dickinson and Company
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Dongguan Jiajie Medical Tech Co., Ltd.
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.